HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,478: | Line 1,478: | ||
| | | | ||
| | | | ||
|Lymphoplasmacytic Lymphoma + Waldenstrom Macroglobulinemia | |(1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia | ||
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and | |(1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI) | ||
|Complete | |Complete | ||
|4/12/2023 by FQR | |4/12/2023 by FQR | ||
| Line 1,576: | Line 1,576: | ||
| | | | ||
|Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity | |Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity | ||
|Follicular Lymphoma + Testicular Follicular Lymphoma | |(1) Follicular Lymphoma + (2) Testicular Follicular Lymphoma | ||
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | |(1 and 2) Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida | ||
|Pending | |Pending | ||
| | | | ||
| Line 1,779: | Line 1,779: | ||
|- | |- | ||
|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| || | |[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| || | ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified + Primary Diffuse Large B-cell Lymphoma of the CNS | |(1) Diffuse Large B-cell Lymphoma, Not Otherwise Specified + (2) Primary Diffuse Large B-cell Lymphoma of the CNS | ||
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital | |(1) Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + (2) Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital | ||
|Pending + Complete | |(1) Pending + (2) Complete | ||
|Not ready + 03/28/22 | |(1) Not ready + (2) 03/28/22 | ||
|For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022 | |For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022 | ||
|- | |- | ||
| Line 1,894: | Line 1,894: | ||
|- | |- | ||
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| || | |Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Cold agglutinin disease | |Cold agglutinin disease | ||